Citadel Advisors’s Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 OPA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-46,877
Closed -$792 15829
2023
Q4
$792 Buy
46,877
+187
+0.4% +$5 ﹤0.01% 13939
2023
Q3
$1.84K Sell
46,690
-995
-2% -$44 ﹤0.01% 13797
2023
Q2
$1.83K Buy
+47,685
New +$2.5K ﹤0.01% 13866

Citadel Advisors's OPA.WS Position: Q1 2024 in Review

Citadel Advisors sold out of Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (OPA.WS) in Q1 2024, closing a stake of 46,877 shares — an estimated $792 sold.

Citadel Advisors first reported a position in OPA.WS in Q2 2023 and held it in 3 quarters. The position peaked at $1.84K in Q3 2023. 0 funds tracked by Wall St. Rank hold OPA.WS as of Q1 2024.

  • Citadel Advisors reported no remaining Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2024 after selling out during the quarter.
  • Citadel Advisors sold 46,877 Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2024, an estimated $792.
  • Citadel Advisors first reported a position in Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q2 2023 and held it in 3 quarters.
  • Citadel Advisors's Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $1.84K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.